Effectiveness and safety of immunosuppressive therapy in neuromyelitis optica spectrum disorder during pregnancy
- 30 March 2017
- journal article
- Published by Elsevier BV in Journal of the Neurological Sciences
- Vol. 377, 72-76
- https://doi.org/10.1016/j.jns.2017.03.051
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Pregnancy in neuromyelitis optica spectrum disorder: A multicenter study from South ChinaJournal of the Neurological Sciences, 2016
- Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorderMultiple Sclerosis Journal, 2016
- International consensus diagnostic criteria for neuromyelitis optica spectrum disordersNeurology, 2015
- Relapse of neuromyelitis optica during pregnancy—Treatment options and literature reviewClinical Neurology and Neurosurgery, 2015
- Neuromyelitis optica and pregnancyZeitschrift für Neurologie, 2013
- Influence of pregnancy on neuromyelitis optica spectrum disorderNeurology, 2012
- Neuromyelitis optica and pregnancyNeurology, 2012
- Devic’s neuromyelitis optica and pregnancy: distinction from multiple sclerosis is essentialArchiv für Gynäkologie, 2009
- The spectrum of neuromyelitis opticaThe Lancet Neurology, 2007
- Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective studyFertility and Sterility, 2003